Launching Q3 2026 in Zurich & Bern

Prevention
comes to you.

Clinically validated preventve screening delivered to Swiss workplaces. Mobile diagnostic fleet. Remote physician oversight. Results within 24 hours.

Swiss Data Protection (nDSG)
ISO 13485 Devices
Physician-Supervised

Targeting partnerships with

UBS ABB Novartis Roche Swisscom Swiss Re CSS Visana

The Prevention Gap

Switzerland spends CHF 2.5 billion on preventve health annually — yet screening still requires patients to visit a clinic during working hours.

28%

of all deaths in Switzerland are caused by cardiovascular disease — the leading cause of mortality (Source: Federal Statistical Office, BFS, 2023)

21 d

average diagnostic latency from GP referral to results — weeks that cost lives

CHF 150M

annual cost of late-stage diagnoses that early screening would have caught

Our Solution

We bring the clinic to the workplace

A fleet of fully equipped mobile diagnostic units visits Swiss workplaces, screening employees during work hours. Remote physician oversight from MEBEKO-recognized German telemedicine doctors ensures clinical quality at 50% lower cost.

  • Results within 24 hours — diagnostic latency cut from 21 days
  • Zero employee travel — 20-minute screening during work hours
  • Full clinical governance — physician-supervised via secure telemedicine link
  • LAMal reimbursement-ready via institutional ZSR model (Unilabs/Medgate precedent)
Healthcare professional with patient during screening
1

Book

Employer schedules a screening day. We handle the rest.

2

Screen

Our van arrives. Nurse and sonographer perform the cardiovascular screening panel.

3

Results

Physician reviews remotely. Results delivered within 24 hours via secure portal.

4

Follow-up

Abnormal findings? Direct referral to specialist. GP notified automatically.

Nurse performing blood draw during workplace screening

Cardiac-Focused Screening Suite

Eight clinically validated exams delivered in a single visit, focused on cardiovascular risk — the leading cause of preventable death in Switzerland.

Echocardiography

Cardiac structure and function assessment. Detects hypertensive heart disease, valvular abnormalities and reduced ejection fraction before symptoms appear.

Carotid Ultrasound (TSA)

Tronchi sovra-aortici scan. Intima-media thickness and atherosclerotic plaque detection — direct stroke risk stratification.

Doppler Ultrasound

Vascular flow analysis. Peripheral arterial disease and venous insufficiency screening for elevated-risk profiles.

Blood Draw

Venous sample for lipid panel, HbA1c, hs-CRP and Lp(a). Lab-grade processing.

FIT Collection

Take-home immunochemical kit for CRC screening. LAMal-covered ages 50-69.

Spirometry

Lung function for smokers and exposed workers. Early COPD detection per ERS.

Anthropometrics

BMI, waist circumference and bioimpedance body composition.

Blood Pressure

Automated clinical-grade measurement. Top modifiable stroke risk factor.

For Employers

Healthier employees.
Stronger bottom line.

Cardiovascular health check at workplace

Mobile preventve screening delivered to your office. Zero disruption, measurable impact on absenteeism and productivity. A wellness benefit your employees will actually use.

-1.5
days absenteeism per employee per year
+4%
productivity gain from early intervention
20 min
per employee — screening during work hours
Echo + TSA
echocardiography + carotid Doppler in a single visit
Schedule a Pilot

Wellness Packages

Essential
FIT (50-69) + BP + Anthropometrics
CHF 150
per participant / year
Popular
Professional
Risk-stratified panel + AGLA/SCORE2 + Dashboard
CHF 250
per participant / year
Executive
Professional + Echo + Carotid US + Coaching
CHF 380
per participant / year

Built for the Swiss healthcare ecosystem

We partner with employers, insurers, hospitals, and clinical research organisations to deliver prevention at scale.

Built to Scale

From 2 vans in Zurich to a national fleet — the numbers behind our capital-efficient telemedicine model.

CHF 2.5bn
Swiss preventve health market
88,000
patients / year capacity at full fleet
50%
lower physician cost via telemedicine
10
mobile units by 2028

Leadership Team

Building at the intersection of Swiss healthcare regulation, telemedicine innovation, and operational excellence.

CEO / Founder

Strategy & Operations

Medical Director

Clinical Governance

CMO

Sales & Partnerships

Clinical Specialist Team

In-house and contracted specialists who own pathway design, second-read interpretation and chronic-disease cohort routing.

Cardiologist

Echo & carotid reads, CV risk pathway

Endocrinologist

Lipids, thyroid, hormone-driven CV risk

Diabetologist

T2DM screening, HbA1c, GLP-1 referral

Nutritionist

Remote follow-up, lifestyle intervention

Advisory Board: Mara H. — Clinical Trial Operations (Pharma) · Health Insurance

See It in Action

Watch how Ventve delivers preventve screening to Swiss workplaces in under 20 minutes.

Frequently Asked Questions

Yes. We operate under the institutional ZSR model -- the same structure used by Unilabs, Synlab, and Medgate. Our German physicians hold MEBEKO recognition and cantonal BAB licenses. We have commissioned a formal legal opinion (Rechtsgutachten) from a Swiss healthcare law firm to confirm LAMal billing eligibility.

A single visit includes up to 8 cardiac-focused exams: echocardiography, carotid (TSA) and Doppler ultrasound, blood draw (lipid panel, HbA1c, hs-CRP, Lp(a)), FIT collection (CRC screening), spirometry, anthropometrics and blood pressure. All performed by a qualified nurse and sonographer under real-time physician supervision. Results delivered within 24 hours via a secure portal; ultrasound studies reviewed by a remote cardiologist.

Packages start at CHF 150 per employee per year (Essential: FIT + Blood Pressure + Anthropometrics) and go up to CHF 380 (Executive: all 8 cardiac-focused exams + lifestyle coaching). Enterprise pricing with quarterly follow-ups is available for large organizations. Volume discounts apply for 500+ employees.

The telemedicine physician is notified immediately. They conduct a video consultation with the patient before they leave the van, explain the findings, and arrange a referral to the appropriate specialist or GP. The patient's primary care physician is also notified automatically.

Yes. We are raising a CHF 2M pre-seed round to fund MEBEKO filings, legal opinions, telemedicine provider contracting, MVP platform development, and acquisition of our first two mobile units. Contact investors@ventve.com for our pitch deck and financial model.

Be the first to know when we launch in your city.

We are launching in Zurich and Bern in Q3 2026. Register your interest and we will notify you when mobile screening is available near you.

Q3 2026
Zurich
Q3 2026
Bern
2027
Basel
2027
Aargau
2027
Vaud
2028+
More cities
Join Waiting List Investors